Sangamo BioSciences | SGMO - Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
Alaunos Therapeutics USD 7M 2M 2026-03
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Alterity Therapeutics Limited AUD 39M 17M 2026-08
Amgen USD 209.65B 14.21B 2026-08
Bayer EUR 48.39B 834.21M 2026-08
BioCryst Pharmaceuticals USD 1.9B 643M 2026-08
Biogen USD 31.9B 5B 2026-06
BioMarin Pharmaceutical USD 11.71B 651M 2026-08
Cipla INR 1.18T 194.93B 2026-06
Clal Biotechnology ILS 43.45M 8.92M 2026-03
Compugen USD 620.29M 475.62M 2026-03
CSL USD 60.19B 4.3B 2026-08
Gilead Sciences USD 168.68B 11.82B 2026-08
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
J&J USD 611.36B 32.21B 2026-06
Karyopharm Therapeutics USD 221M 95M 2026-08
Merck USD 324.18B 6.81B 2026-08
Novartis USD 240.59B 67.17B 2026-06
Pfizer USD 153.17B 14.73B 2026-08
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 91.15B 9.12B 2026-06
Sarepta Therapeutics USD 1.5B 402M 2026-08
Tectonic Therapeutic USD 580M 190M 2026-03
Ultragenyx Pharmaceutical USD 2.12B 1.16B 2026-08
Vertex Pharmaceuticals USD 137.33B 11.26B 2026-08